Switzerland’s Sandoz sees Canada and Brazil markets as testing grounds before semaglutide goes off patent in Europe and the U ...
Q1 2026 trading update and why it matters for Sandoz shares Sandoz Group (SWX:SDZ) has just reported its Q1 2026 trading update, with 3% net sales growth at constant currencies and an 18% rise in ...
Sandoz is doubling down on its commitment to Slovenia in its globe-trotting biosimilar growth quest. The Novartis generics unit is plugging $90 million into a new biosimilar technical development ...
Ever wondered if Sandoz Group stock could be a hidden value play, or if you're just jumping in after the most exciting moves? Let's find out what might actually be under the hood. After a rocky 2.4% ...
In March 2026, Sandoz and Samsung Bioepis entered a strategic partnership covering up to five biosimilar assets, with the ...
LONDON (Reuters) - Novartis' soon-to-be spun off generics division Sandoz is betting on biosimilars, copies of high-priced drugs used to treat illnesses such as rheumatoid arthritis and cancer, to ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
(Reuters) -Sandoz shares dipped on their market debut on Wednesday after the generic and biosimilar drugmaker was valued at a lower-than-expected 10.3 billion Swiss francs ($11.2 billion) in its ...
At an Extraordinary General Meeting, Novartis AG's (NYSE:NVS) shareholders approved the proposed 100% spin-off of Sandoz. Novartis shareholders and Novartis ADR holders will receive one Sandoz share ...
(RTTNews) - Sandoz, Novartis AG's (NVS) generics and biosimilars division, announced Monday plans for a joint investment with Austrian federal government for large-scale manufacture of active ...
When Novartis unveiled a plan in 2018 to grant its Sandoz generics business more autonomy, industry watchers read spinoff. Now, a separation may be around the corner. Novartis has launched a strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results